Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival.

Cancer management and research

Tantraworasin A, Saeteng S, Lertprasertsuke N, Arayawudhikul N, Kasemsarn C, Patumanond J.
PMID: 24124391
Cancer Manag Res. 2013 Oct 03;5:327-36. doi: 10.2147/CMAR.S52073. eCollection 2013.

BACKGROUND: The roles of excision repair cross-complementing group 1 gene (ERCC1) expression and ribonucleotide reductase subunit M1 gene (RRM1) expression in completely resected non-small cell lung cancer (NSCLC) are still debatable. Previous studies have shown that both genes affected...

Cite
Tantraworasin A, Saeteng S, Lertprasertsuke N, et al. The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival. Cancer Manag Res. 2013;5:327-36doi: 10.2147/CMAR.S52073.
Tantraworasin, A., Saeteng, S., Lertprasertsuke, N., Arayawudhikul, N., Kasemsarn, C., & Patumanond, J. (2013). The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival. Cancer management and research, 5327-36. https://doi.org/10.2147/CMAR.S52073
Tantraworasin, Apichat, et al. "The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival." Cancer management and research vol. 5 (2013): 327-36. doi: https://doi.org/10.2147/CMAR.S52073
Tantraworasin A, Saeteng S, Lertprasertsuke N, Arayawudhikul N, Kasemsarn C, Patumanond J. The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival. Cancer Manag Res. 2013 Oct 03;5:327-36. doi: 10.2147/CMAR.S52073. eCollection 2013. PMID: 24124391; PMCID: PMC3794893.
Copy Download .nbib Format: NLM
Tracheal Capillary Hemangioma Successfully Treated With Combined Bronchoscopic Cryotherapy and Argon-Plasma Coagulation.

Cureus

Ruenwilai P, Liwsrisakun C, Limsukon A, Bumroongkit C, Lertprasertsuk N.
PMID: 34754691
Cureus. 2021 Oct 06;13(10):e18547. doi: 10.7759/cureus.18547. eCollection 2021 Oct.

We report a 43-year-old female who presented with recurrent non-massive hemoptysis for four months. Chest radiograph was normal. Thoracic computed tomography (CT) scan revealed a 0.8-centimeter intraluminal polypoid mass abutting the middle part of trachea. A fiber-optic bronchoscopy demonstrated...

Cite
Ruenwilai P, Liwsrisakun C, Limsukon A, et al. Tracheal Capillary Hemangioma Successfully Treated With Combined Bronchoscopic Cryotherapy and Argon-Plasma Coagulation. Cureus. 2021;13(10):e18547doi: 10.7759/cureus.18547.
Ruenwilai, P., Liwsrisakun, C., Limsukon, A., Bumroongkit, C., & Lertprasertsuk, N. (2021). Tracheal Capillary Hemangioma Successfully Treated With Combined Bronchoscopic Cryotherapy and Argon-Plasma Coagulation. Cureus, 13(10), e18547. https://doi.org/10.7759/cureus.18547
Ruenwilai, Parinya, et al. "Tracheal Capillary Hemangioma Successfully Treated With Combined Bronchoscopic Cryotherapy and Argon-Plasma Coagulation." Cureus vol. 13,10 (2021): e18547. doi: https://doi.org/10.7759/cureus.18547
Ruenwilai P, Liwsrisakun C, Limsukon A, Bumroongkit C, Lertprasertsuk N. Tracheal Capillary Hemangioma Successfully Treated With Combined Bronchoscopic Cryotherapy and Argon-Plasma Coagulation. Cureus. 2021 Oct 06;13(10):e18547. doi: 10.7759/cureus.18547. eCollection 2021 Oct. PMID: 34754691; PMCID: PMC8570915.
Copy Download .nbib Format: NLM
Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival.

ISRN surgery

Tantraworasin A, Saeteng S, Lertprasertsuke N, Arayawudhikule N, Kasemsarn C, Patumanond J.
PMID: 24073341
ISRN Surg. 2013 Aug 29;2013:175304. doi: 10.1155/2013/175304. eCollection 2013.

Background. Although early stage non-small cell lung cancer (NSCLC) has an excellent outcome and correlated with good long-term survival, up to 15 percent of patients still relapse postoperatively and die. This study is conducted to identify prognostic factors that...

Cite
Tantraworasin A, Saeteng S, Lertprasertsuke N, et al. Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival. ISRN Surg. 2013;2013:175304doi: 10.1155/2013/175304.
Tantraworasin, A., Saeteng, S., Lertprasertsuke, N., Arayawudhikule, N., Kasemsarn, C., & Patumanond, J. (2013). Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival. ISRN surgery, 2013175304. https://doi.org/10.1155/2013/175304
Tantraworasin, Apichat, et al. "Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival." ISRN surgery vol. 2013 (2013): 175304. doi: https://doi.org/10.1155/2013/175304
Tantraworasin A, Saeteng S, Lertprasertsuke N, Arayawudhikule N, Kasemsarn C, Patumanond J. Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival. ISRN Surg. 2013 Aug 29;2013:175304. doi: 10.1155/2013/175304. eCollection 2013. PMID: 24073341; PMCID: PMC3773441.
Copy Download .nbib Format: NLM
Conjunctival Intraepithelial Neoplasia in a Patient Presenting with Pigmented Conjunctival Lesion.

Case reports in ophthalmology

Chaidaroon W, Dejkriengkraikul C, Isipradit S, Lertprasertsuke N.
PMID: 33613255
Case Rep Ophthalmol. 2021 Jan 21;12(1):77-82. doi: 10.1159/000510570. eCollection 2021.

We report a case of conjunctival intraepithelial neoplasia (CIN) in a patient presenting with the pigmented conjunctival lesion. This study involved a 56-year-old woman that presented with right eye irritation for 1 month. She noticed brownish pigmentation arising from...

Cite
Chaidaroon W, Dejkriengkraikul C, Isipradit S, et al. Conjunctival Intraepithelial Neoplasia in a Patient Presenting with Pigmented Conjunctival Lesion. Case Rep Ophthalmol. 2021;12(1):77-82doi: 10.1159/000510570.
Chaidaroon, W., Dejkriengkraikul, C., Isipradit, S., & Lertprasertsuke, N. (2021). Conjunctival Intraepithelial Neoplasia in a Patient Presenting with Pigmented Conjunctival Lesion. Case reports in ophthalmology, 12(1), 77-82. https://doi.org/10.1159/000510570
Chaidaroon, Winai, et al. "Conjunctival Intraepithelial Neoplasia in a Patient Presenting with Pigmented Conjunctival Lesion." Case reports in ophthalmology vol. 12,1 (2021): 77-82. doi: https://doi.org/10.1159/000510570
Chaidaroon W, Dejkriengkraikul C, Isipradit S, Lertprasertsuke N. Conjunctival Intraepithelial Neoplasia in a Patient Presenting with Pigmented Conjunctival Lesion. Case Rep Ophthalmol. 2021 Jan 21;12(1):77-82. doi: 10.1159/000510570. eCollection 2021. PMID: 33613255; PMCID: PMC7879333.
Copy Download .nbib Format: NLM
Nodal involvement pattern in resectable lung cancer according to tumor location.

Cancer management and research

Saeteng S, Tantraworasin A, Euathrongchit J, Lertprasertsuke N, Wannasopha Y.
PMID: 22740775
Cancer Manag Res. 2012;4:151-8. doi: 10.2147/CMAR.S30526. Epub 2012 Jun 07.

The aim in this study was to define the pattern of lymph node metastasis according to the primary tumor location. In this retrospective cohort study, each of the operable patients diagnosed with lung cancer was grouped by tumor mass...

Cite
Saeteng S, Tantraworasin A, Euathrongchit J, et al. Nodal involvement pattern in resectable lung cancer according to tumor location. Cancer Manag Res. 2012;4:151-8doi: 10.2147/CMAR.S30526.
Saeteng, S., Tantraworasin, A., Euathrongchit, J., Lertprasertsuke, N., & Wannasopha, Y. (2012). Nodal involvement pattern in resectable lung cancer according to tumor location. Cancer management and research, 4151-8. https://doi.org/10.2147/CMAR.S30526
Saeteng, Somcharoen, et al. "Nodal involvement pattern in resectable lung cancer according to tumor location." Cancer management and research vol. 4 (2012): 151-8. doi: https://doi.org/10.2147/CMAR.S30526
Saeteng S, Tantraworasin A, Euathrongchit J, Lertprasertsuke N, Wannasopha Y. Nodal involvement pattern in resectable lung cancer according to tumor location. Cancer Manag Res. 2012;4:151-8. doi: 10.2147/CMAR.S30526. Epub 2012 Jun 07. PMID: 22740775; PMCID: PMC3379857.
Copy Download .nbib Format: NLM
Preoperative plasmapheresis for elective thymectomy in myasthenia patient: is it necessary?.

ISRN neurology

Saeteng S, Tantraworasin A, Siwachat S, Lertprasertsuke N, Euathrongchit J, Wannasopha Y.
PMID: 23840964
ISRN Neurol. 2013 Jun 11;2013:238783. doi: 10.1155/2013/238783. Print 2013.

Background. Role of plasmapheresis before thymectomy remains controversial. The aim of this study is to determine the peri-operative and post-operative outcome of a thymectomy between performing and not performing a pre-operative plasmaphreresis. Patients and Methods. A retrospective chart review...

Cite
Saeteng S, Tantraworasin A, Siwachat S, et al. Preoperative plasmapheresis for elective thymectomy in myasthenia patient: is it necessary?. ISRN Neurol. 2013;2013:238783doi: 10.1155/2013/238783.
Saeteng, S., Tantraworasin, A., Siwachat, S., Lertprasertsuke, N., Euathrongchit, J., & Wannasopha, Y. (2013). Preoperative plasmapheresis for elective thymectomy in myasthenia patient: is it necessary?. ISRN neurology, 2013238783. https://doi.org/10.1155/2013/238783
Saeteng, Somcharoen, et al. "Preoperative plasmapheresis for elective thymectomy in myasthenia patient: is it necessary?." ISRN neurology vol. 2013 (2013): 238783. doi: https://doi.org/10.1155/2013/238783
Saeteng S, Tantraworasin A, Siwachat S, Lertprasertsuke N, Euathrongchit J, Wannasopha Y. Preoperative plasmapheresis for elective thymectomy in myasthenia patient: is it necessary?. ISRN Neurol. 2013 Jun 11;2013:238783. doi: 10.1155/2013/238783. Print 2013. PMID: 23840964; PMCID: PMC3693175.
Copy Download .nbib Format: NLM
Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer.

Cancer management and research

Tantraworasin A, Saeteng S, Lertprasertsuke N, Arreyakajohn N, Kasemsarn C, Patumanond J.
PMID: 23785244
Cancer Manag Res. 2013 Jun 06;5:77-84. doi: 10.2147/CMAR.S45642. Print 2013.

BACKGROUND: Patients with completely resected non-small cell lung cancer (NSCLC) have an excellent outcome; however tumor recurs in 30%-77% of patients. This study retrospectively analyzed the clinicopathologic features of patients with any operable stage of NSCLC to identify the...

Cite
Tantraworasin A, Saeteng S, Lertprasertsuke N, et al. Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer. Cancer Manag Res. 2013;5:77-84doi: 10.2147/CMAR.S45642.
Tantraworasin, A., Saeteng, S., Lertprasertsuke, N., Arreyakajohn, N., Kasemsarn, C., & Patumanond, J. (2013). Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer. Cancer management and research, 577-84. https://doi.org/10.2147/CMAR.S45642
Tantraworasin, Apichat, et al. "Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer." Cancer management and research vol. 5 (2013): 77-84. doi: https://doi.org/10.2147/CMAR.S45642
Tantraworasin A, Saeteng S, Lertprasertsuke N, Arreyakajohn N, Kasemsarn C, Patumanond J. Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer. Cancer Manag Res. 2013 Jun 06;5:77-84. doi: 10.2147/CMAR.S45642. Print 2013. PMID: 23785244; PMCID: PMC3682816.
Copy Download .nbib Format: NLM
Impact of lymph node management on resectable non-small cell lung cancer patients.

Journal of thoracic disease

Tantraworasin A, Saeteng S, Siwachat S, Jiarawasupornchai T, Lertprasertsuke N, Kongkarnka S, Ruengorn C, Patumanond J, Taioli E, Flores RM.
PMID: 28449474
J Thorac Dis. 2017 Mar;9(3):666-674. doi: 10.21037/jtd.2017.02.90.

BACKGROUND: A surgical lung resection with systematic mediastinal lymph node (LN) dissection is recommended by the National Comprehensive Cancer Network guideline. However, the effective number of dissected LNs, stations and positivity is still controversial. The aim of this study...

Cite
Tantraworasin A, Saeteng S, Siwachat S, et al. Impact of lymph node management on resectable non-small cell lung cancer patients. J Thorac Dis. 2017;9(3):666-674doi: 10.21037/jtd.2017.02.90.
Tantraworasin, A., Saeteng, S., Siwachat, S., Jiarawasupornchai, T., Lertprasertsuke, N., Kongkarnka, S., Ruengorn, C., Patumanond, J., Taioli, E., & Flores, R. M. (2017). Impact of lymph node management on resectable non-small cell lung cancer patients. Journal of thoracic disease, 9(3), 666-674. https://doi.org/10.21037/jtd.2017.02.90
Tantraworasin, Apichat, et al. "Impact of lymph node management on resectable non-small cell lung cancer patients." Journal of thoracic disease vol. 9,3 (2017): 666-674. doi: https://doi.org/10.21037/jtd.2017.02.90
Tantraworasin A, Saeteng S, Siwachat S, Jiarawasupornchai T, Lertprasertsuke N, Kongkarnka S, Ruengorn C, Patumanond J, Taioli E, Flores RM. Impact of lymph node management on resectable non-small cell lung cancer patients. J Thorac Dis. 2017 Mar;9(3):666-674. doi: 10.21037/jtd.2017.02.90. PMID: 28449474; PMCID: PMC5394018.
Copy Download .nbib Format: NLM
Effect of Insurance Type on Stage at Presentation, Surgical Approach, Tumor Recurrence and Cancer-Specific Survival in Resectable Non-Small Lung Cancer Patients.

Risk management and healthcare policy

Siwachat S, Lertprasertsuke N, Tanatip N, Kongkarnka S, Euathrongchit J, Wannasopha Y, Suksombooncharoen T, Chewaskulyong B, Lieberman-Cribbin W, Taioli E, Saeteng S, Tantraworasin A.
PMID: 32607024
Risk Manag Healthc Policy. 2020 Jun 12;13:559-569. doi: 10.2147/RMHP.S244344. eCollection 2020.

PURPOSE: The aim of this study was to identify the association between Thailand's insurance types and stage at presentation, surgical approach, tumor recurrence and cancer-specific survival in resectable non-small cell lung cancer (NSCLC) patients in northern Thailand.PATIENTS AND METHODS:...

Cite
Siwachat S, Lertprasertsuke N, Tanatip N, et al. Effect of Insurance Type on Stage at Presentation, Surgical Approach, Tumor Recurrence and Cancer-Specific Survival in Resectable Non-Small Lung Cancer Patients. Risk Manag Healthc Policy. 2020;13:559-569doi: 10.2147/RMHP.S244344.
Siwachat, S., Lertprasertsuke, N., Tanatip, N., Kongkarnka, S., Euathrongchit, J., Wannasopha, Y., Suksombooncharoen, T., Chewaskulyong, B., Lieberman-Cribbin, W., Taioli, E., Saeteng, S., & Tantraworasin, A. (2020). Effect of Insurance Type on Stage at Presentation, Surgical Approach, Tumor Recurrence and Cancer-Specific Survival in Resectable Non-Small Lung Cancer Patients. Risk management and healthcare policy, 13559-569. https://doi.org/10.2147/RMHP.S244344
Siwachat, Sophon, et al. "Effect of Insurance Type on Stage at Presentation, Surgical Approach, Tumor Recurrence and Cancer-Specific Survival in Resectable Non-Small Lung Cancer Patients." Risk management and healthcare policy vol. 13 (2020): 559-569. doi: https://doi.org/10.2147/RMHP.S244344
Siwachat S, Lertprasertsuke N, Tanatip N, Kongkarnka S, Euathrongchit J, Wannasopha Y, Suksombooncharoen T, Chewaskulyong B, Lieberman-Cribbin W, Taioli E, Saeteng S, Tantraworasin A. Effect of Insurance Type on Stage at Presentation, Surgical Approach, Tumor Recurrence and Cancer-Specific Survival in Resectable Non-Small Lung Cancer Patients. Risk Manag Healthc Policy. 2020 Jun 12;13:559-569. doi: 10.2147/RMHP.S244344. eCollection 2020. PMID: 32607024; PMCID: PMC7297449.
Copy Download .nbib Format: NLM
Postoperative Pericardial Adhesion Prevention Using Collagen Membrane in Pigs: A Pilot Study.

Open journal of cardiovascular surgery

Taksaudom N, Ketwong M, Lertprasertsuke N, Kongkaew A.
PMID: 28781517
Open J Cardiovasc Surg. 2017 Jul 17;9:1179065217720909. doi: 10.1177/1179065217720909. eCollection 2017.

OBJECTIVE: The operating procedure of a resternotomy in open-heart surgery is a complicated procedure with potentially problematic outcomes partly due to potential adhesions in the pericardial cavity and retrosternal space. Use of a collagen membrane has shown encouraging results...

Cite
Taksaudom N, Ketwong M, Lertprasertsuke N, et al. Postoperative Pericardial Adhesion Prevention Using Collagen Membrane in Pigs: A Pilot Study. Open J Cardiovasc Surg. 2017;9:1179065217720909doi: 10.1177/1179065217720909.
Taksaudom, N., Ketwong, M., Lertprasertsuke, N., & Kongkaew, A. (2017). Postoperative Pericardial Adhesion Prevention Using Collagen Membrane in Pigs: A Pilot Study. Open journal of cardiovascular surgery, 91179065217720909. https://doi.org/10.1177/1179065217720909
Taksaudom, Noppon, et al. "Postoperative Pericardial Adhesion Prevention Using Collagen Membrane in Pigs: A Pilot Study." Open journal of cardiovascular surgery vol. 9 (2017): 1179065217720909. doi: https://doi.org/10.1177/1179065217720909
Taksaudom N, Ketwong M, Lertprasertsuke N, Kongkaew A. Postoperative Pericardial Adhesion Prevention Using Collagen Membrane in Pigs: A Pilot Study. Open J Cardiovasc Surg. 2017 Jul 17;9:1179065217720909. doi: 10.1177/1179065217720909. eCollection 2017. PMID: 28781517; PMCID: PMC5518959.
Copy Download .nbib Format: NLM
CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma.

Hepatic oncology

Raunroadroong N, Sriplung H, Lertprasertsuke N, Pojchamarnwiputh S, Chiangmai WN, Sinsuwan W, Thongprasert S.
PMID: 30190973
Hepat Oncol. 2014 Oct;1(4):377-386. doi: 10.2217/hep.14.19. Epub 2014 Dec 11.

AIM: Cholangiocarcinoma (CCA) is a common form of cancer in Thailand. The diagnosis of CCA by pathology is widely accepted. Unfortunately, tissue diagnosis of mass-forming intrahepatic cholangiocarcinoma is difficult to perform due to the risk of the procedure and...

Cite
Raunroadroong N, Sriplung H, Lertprasertsuke N, et al. CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma. Hepat Oncol. 2014;1(4):377-386doi: 10.2217/hep.14.19.
Raunroadroong, N., Sriplung, H., Lertprasertsuke, N., Pojchamarnwiputh, S., Chiangmai, W. N., Sinsuwan, W., & Thongprasert, S. (2014). CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma. Hepatic oncology, 1(4), 377-386. https://doi.org/10.2217/hep.14.19
Raunroadroong, Nilubol, et al. "CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma." Hepatic oncology vol. 1,4 (2014): 377-386. doi: https://doi.org/10.2217/hep.14.19
Raunroadroong N, Sriplung H, Lertprasertsuke N, Pojchamarnwiputh S, Chiangmai WN, Sinsuwan W, Thongprasert S. CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma. Hepat Oncol. 2014 Oct;1(4):377-386. doi: 10.2217/hep.14.19. Epub 2014 Dec 11. PMID: 30190973; PMCID: PMC6095427.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries